ReviewCureus2023

Comparison of Effectiveness and Safety of Low-Dose Versus Standard-Dose Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke: A Meta-Analysis.

Jithin Karedath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.